pre-IPO PHARMA

COMPANY OVERVIEW

IGF Oncology is a biotech company developing targeted anti-cancer drugs with better efficacy and lower side effects compared to existing chemotherapy treatments. Our lead drug, IGF-MTX, targets the deadly blood cancer MDS, and is currently in clinical trials at the Mayo Clinic, and the results so far are very promising.


LOCATION

  • St. Paul, MN, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://igfoncology.com


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Apr 8, 2019

    IGF Oncology Appoints Gary G. Altman, Ph.D., as Chief Executive Officer


    Dec 20, 2018

    IGF Oncology to Present at Biotech Showcase 2019


    For More Press Releases


    Google Analytics Alternative